Items where authors include "Bluett, J."

Article

Yap, C.F., Nair, N., Sharma, S.D. et al. (12 more authors) (2025) Comparative Effectiveness of Abatacept versus Adalimumab in Shared Epitope positive and negative Rheumatoid Arthritis patients. Arthritis & Rheumatology. ISSN 2326-5191 (In Press)

Abhishek, A. orcid.org/0000-0003-0121-4919, Peckham, N. orcid.org/0000-0003-1066-0726, Pade, C. orcid.org/0000-0003-0626-2346 et al. (22 more authors) (2025) Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT. Efficacy and Mechanism Evaluation. ISSN 2050-4365

Quick, V., Abusalameh, M., Ahmed, S. et al. (72 more authors) (2024) Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England. Rheumatology, 63 (12). pp. 3407-3414. ISSN 1462-0324

Ling, S.F. orcid.org/0000-0001-8148-2344, Ogungbenro, K., Darwich, A.S. orcid.org/0000-0001-8218-4306 et al. (9 more authors) (2024) Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis. Pharmaceutics, 16 (6). 702. ISSN 1999-4923

Lyon, M. orcid.org/0000-0003-4845-1743, Zhao, S.S., Jani, M. orcid.org/0000-0002-1487-277X et al. (132 more authors) (2024) The influence of deprivation in the outcomes of psoriatic arthritis within the UK—utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data. Rheumatology Advances in Practice, 8 (2). rkae051. ISSN 2514-1775

Abhishek, A., Peckham, N., Pade, C. et al. (65 more authors) (2024) Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet Rheumatology, 6 (2). e92-e104. ISSN 2665-9913

Curry, P.D.K. orcid.org/0000-0003-0013-460X, Morris, A.P. orcid.org/0000-0002-6805-6014, Jani, M. orcid.org/0000-0002-1487-277X et al. (133 more authors) (2024) Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response. Rheumatology Advances in Practice, 8 (1). rkae014. ISSN 2514-1775

Curry, P.D.K. orcid.org/0000-0003-0013-460X, Chinoy, H. orcid.org/0000-0001-6492-1288, Jani, M. orcid.org/0000-0002-1487-277X et al. (8 more authors) (2023) The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort. The Journal of Rheumatology, 50 (11). pp. 1518-1521. ISSN 0315-162X

Ling, S.F. orcid.org/0000-0001-8148-2344, Yap, C.F., Nair, N. orcid.org/0000-0001-9829-792X et al. (7 more authors) (2023) A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures. Rheumatology. kead321. ISSN 1462-0324

Abhishek, A., Boyton, R.J., McKnight, Á. et al. (15 more authors) (2022) Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study). BMJ Open, 12 (5). e062599. ISSN 2044-6055